Aurobindo Pharma Ltd has announced that the US FDA has successfully inspected and rated Unit XI at Vizag in Andhra Pradesh, one of the API manufacturing facilities, as "Acceptable" (complying with all cGMP requirements).
The company is also delighted to share that the inspection has been successful without any 483s.
The facility is spread over 110 acres of land and consists of eleven production blocks. It is one of the prestigious and biggest manufacturing facility of the company. Apart from US FDA approval, this facility also holds local FDA, WHO GMP Certificate (Drug Control Administration. A.P., India) and ISO 9001-2000 certification.